Genetics examined in tamoxifen's effectiveness: recurrence warning urged for labeling.
Young
Donna
D
D000483:Alleles; D000928:Antidepressive Agents / Q000493:pharmacokinetics / Q000627:therapeutic use; D018931:Antineoplastic Agents, Hormonal / Q000037:antagonists & inhibitors / Q000493:pharmacokinetics* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy / Q000235:genetics* / Q000378:metabolism; D019389:Cytochrome P-450 CYP2D6 / Q000235:genetics* / Q000378:metabolism; D003863:Depression / Q000188:drug therapy; D004347:Drug Interactions; D004348:Drug Labeling; D005260:Female; D006801:Humans; D010597:Pharmacogenetics; D012008:Recurrence; D013629:Tamoxifen / Q000037:antagonists & inhibitors / Q000493:pharmacokinetics* / Q000627:therapeutic use
D000928:Antidepressive Agents; D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen; D019389:Cytochrome P-450 CYP2D6